Literature DB >> 9107531

Effectiveness of partial splenectomy in hereditary spherocytosis.

G Tchernia1, B Bader-Meunier, P Berterottiere, S Eber, J P Dommergues, F Gauthier.   

Abstract

Total splenectomy eliminates the splenic destruction of erythrocytes with impaired deformability. However, concern has increased over the lifelong risk of overwhelming postsplenectomy infections in splenectomized patients, a risk reduced but not totally suppressed by appropriate prophylaxis. Partial splenectomy, as long as 80% to 90% of the enlarged spleen is removed and less than 25% of the normal spleen volume is retained, is a logical alternative, both preserving the phagocytic and immune function of the spleen and decreasing erythrocyte destruction. A 12-year experience has shown that subtotal splenectomy is efficient in decreasing hemolysis, although to a lesser extent than total splenectomy, with sustained results over years in most patients, and indirect evidence argues for the integrity of phagocytic function. Such a surgical procedure should be considered in transfusion-dependent infants with hereditary spherocytosis and in older patients with erythrocyte membrane defects, provided further follow-up confirms the experience of the past 12 years.

Entities:  

Mesh:

Year:  1997        PMID: 9107531     DOI: 10.1097/00062752-199704020-00010

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  10 in total

1.  Clinical and hematologic benefits of partial splenectomy for congenital hemolytic anemias in children.

Authors:  Henry E Rice; Keith T Oldham; Cheryl A Hillery; Michael A Skinner; Sara M O'Hara; Russell E Ware
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

2.  Laparoscopic versus robotic subtotal splenectomy in hereditary spherocytosis. Potential advantages and limits of an expensive approach.

Authors:  Catalin Vasilescu; Oana Stanciulea; Stefan Tudor
Journal:  Surg Endosc       Date:  2012-04-05       Impact factor: 4.584

3.  Laparoscopic subtotal splenectomy in hereditary spherocytosis.

Authors:  C Vasilescu; O Stanciulea; C Arion
Journal:  Surg Endosc       Date:  2007-09       Impact factor: 4.584

Review 4.  Hereditary spherocytosis and partial splenectomy in children: review of surgical technique and the role of imaging.

Authors:  Caroline L Hollingsworth; Henry E Rice
Journal:  Pediatr Radiol       Date:  2010-02-24

Review 5.  Partial splenectomy in the era of minimally invasive surgery: the current laparoscopic and robotic experiences.

Authors:  Alexandre Balaphas; Nicolas C Buchs; Jeremy Meyer; Monika E Hagen; Philippe Morel
Journal:  Surg Endosc       Date:  2015-03-05       Impact factor: 4.584

6.  A laparoscopic approach to partial splenectomy for children with hereditary spherocytosis.

Authors:  S Dutta; V E Price; V Blanchette; J C Langer
Journal:  Surg Endosc       Date:  2006-10-05       Impact factor: 4.584

7.  Evaluation of partial and total splenectomy in children with sickle cell disease using an Internet-based registry.

Authors:  Sofia Mouttalib; Henry E Rice; Denise Snyder; Justin S Levens; Audra Reiter; Pauline Soler; Jennifer A Rothman; Courtney D Thornburg
Journal:  Pediatr Blood Cancer       Date:  2012-01-11       Impact factor: 3.167

8.  Near-total splenectomy: a new technique for the management of hereditary spherocytosis.

Authors:  Gerhard A Stoehr; Urs G Stauffer; Stefan W Eber
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

9.  Prevention of overwhelming postsplenectomy infection in thalassemia patients by partial rather than total splenectomy.

Authors:  Anwar K Sheikha; Ziyan T Salih; Kalandar H Kasnazan; Mohammad K Khoshnaw; Talal Al-Maliki; Tarek A Al-Azraqi; Mubarak H Zafer
Journal:  Can J Surg       Date:  2007-10       Impact factor: 2.089

10.  Laparoscopic subtotal splenectomy in hereditary spherocytosis : to preserve the upper or the lower pole of the spleen?

Authors:  C Vasilescu; O Stanciulea; S Tudor; D Stanescu; A Colita; R Stoia; D Coriu; A Colita; C Arion
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.